Abstract
Mitral stenosis (MS) has a well-established female predominance and, although now rare in developed countries, continues to be responsible for a large burden of disease worldwide due to its association with rheumatic fever, which is still endemic in the developing world. Despite the ease of investigation and management, it remains an important cause of morbidity. Percutaneous balloon mitral valvuloplasty (PBMV) is the gold standard in the management of these patients, commonly by the Inoue or double-balloon technique. There are anatomical and technical considerations that need to be taken into account during mitral valvuloplasty in women. Compared with males, females have a larger pre-procedural mitral valve area (MVA), less calcification and more favourable anatomy which may affect decisions on balloon sizing. Unique to women, special consideration needs to be made when considering mitral valvuloplasty during pregnancy. Echocardiography, and increasingly 3D echocardiography, is the cornerstone of patient assessment and its use to select patients with appropriate anatomy and leads to very good short- and long-term outcomes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet. 2009;374(9697):1271–83.
Nobuyoshi M, Arita T, Shirai S, Hamasaki N, Yokoi H, Iwabuchi M, et al. Percutaneous balloon mitral valvuloplasty: a review. Circulation. 2009;119(8):e211–9.
Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231–43.
Shiota T. Role of modern 3D echocardiography in valvular heart disease. Korean J Intern Med. 2014;29(6):685–702.
Reyes VP, Raju BS, Wynne J, Stephenson LW, Raju R, Fromm BS, et al. Percutaneous balloon valvuloplasty compared with open surgical commissurotomy for mitral stenosis. N Engl J Med. 1994;331(15):961–7.
Sakr SA, Ramadan MM, Osama M. A novel technique for multi-track percutaneous balloon mitral valvoplasty. Int Heart J. 2013;54(4):196–201.
Harikrishnan S, Bhat A, Tharakan J, Titus T, Kumar A, Sivasankaran S, et al. Percutaneous transvenous mitral commissurotomy using metallic commissurotome: long-term follow-up results. J Invasive Cardiol. 2006;18(2):54–8.
Joint Task Force on the Management of Valvular Heart Disease of the European Society of C, European Association for Cardio-Thoracic S, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96.
Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin 3rd JP, Guyton RA, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(23):e521–643.
Cavalcante JL, Rodriguez LL, Kapadia S, Tuzcu EM, Stewart WJ. Role of echocardiography in percutaneous mitral valve interventions. JACC Cardiovasc Imaging. 2012;5(7):733–46.
Cruz-Gonzalez I, Jneid H, Sanchez-Ledesma M, Cubeddu RJ, Martin-Moreiras J, Rengifo-Moreno P, et al. Difference in outcome among women and men after percutaneous mitral valvuloplasty. Catheter Cardiovasc Interv. 2011;77(1):115–20.
Yetkin E, Qehreli S, Ileri M, Senen K, Enen, Atak R, et al. Comparison of clinical echocardiographic and hemodynamic characteristics of male and female patients who underwent mitral balloon valvuloplasty. Angiology. 2001;52(12):835–9.
Dreyfus J, Cimadevilla C, Nguyen V, Brochet E, Lepage L, Himbert D, et al. Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. Eur Heart J. 2014;35(24):1617–23.
Bouleti C, Iung B, Laouenan C, Himbert D, Brochet E, Messika-Zeitoun D, et al. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of a risk score predicting late functional results from a series of 912 patients. Circulation. 2012;125(17):2119–27.
Akram MR, Chan T, McAuliffe S, Chenzbraun A. Non-rheumatic annular mitral stenosis: prevalence and characteristics. Eur J Echocardiogr. 2009;10(1):103–5.
Maisano F. Expanding the indications for percutaneous mitral commmissurotomy in rheumatic mitral stenosis: look carefully at the commissures, and proceed cautiously and skilfully. Eur Heart J. 2014;35(24):1575–7.
Sarath Babu D, Ranganayakulu KP, Rajasekhar D, Vanajakshamma V, Pramod Kumar T. Assessment of mitral valve commissural morphology by transoesophageal echocardiography predicts outcome after balloon mitral valvotomy. Indian Heart J. 2013;65(3):269–75.
Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112(3):432–7.
European Society of G, Association for European Paediatric C, German Society for Gender M, Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011;32(24):3147–97.
A G, W K, Fa N, Me F. Mitral balloon valvuloplasty during pregnancy: the long term up to 17 years obstetric outcome and childhood development. Pak J Med Sci. 2014;30(1):86–90.
Leon MN, Harrell LC, Simosa HF, Mahdi NA, Pathan A, Lopez-Cuellar J, et al. Mitral balloon valvotomy for patients with mitral stenosis in atrial fibrillation: immediate and long-term results. J Am Coll Cardiol. 1999;34(4):1145–52.
Sanati HR, Zahedmehr A, Shakerian F, Bakhshandeh H, Firoozi A, Kiani R, et al. Percutaneous mitral valvuloplasty using echocardiographic intercommissural diameter as reference for balloon sizing: a randomized controlled trial. Clin Cardiol. 2012;35(12):749–54.
Schlosshan D, Aggarwal G, Mathur G, Allan R, Cranney G. Real-time 3D transesophageal echocardiography for the evaluation of rheumatic mitral stenosis. JACC Cardiovasc Imaging. 2011;4(6):580–8.
Tomai F, Gaspardone A, Versaci F, Ghini AS, Altamura L, De Luca L, et al. Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis. Int J Cardiol. 2014;177(3):881–5.
Wilkins GT, et al. Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. Br Heart J. 1988;60(4):299–308.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Beska, B., Eggett, C., Kunadian, V. (2017). Mitral Valvuloplasty for Mitral Stenosis. In: Presbitero, P., Mehilli, J., Petronio, A. (eds) Percutaneous Treatment of Cardiovascular Diseases in Women. Springer, Cham. https://doi.org/10.1007/978-3-319-39611-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-39611-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-39609-5
Online ISBN: 978-3-319-39611-8
eBook Packages: MedicineMedicine (R0)